Vesair Clinical Trial

NCT04026347 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2022-05-13

No results posted yet for this study

Summary

Single-blind, multicenter, randomized clinical trial of the Vesair Balloon in the treatment of Stress Urinary Incontinence in post-menopausal women

Conditions

  • Stress Urinary Incontinence

Interventions

DEVICE

Vesair Balloon

Indwelling, intravesical balloon

OTHER

Sham balloon placement

Sham balloon placement procedure

Sponsors & Collaborators

  • Solace Therapeutics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2022-02-28
Completion
2022-04-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04026347 on ClinicalTrials.gov